Frontline Genomics talks to Ranga Sarangarajan about our AI guided GBM trials

March 10, 2017

BERG’s Chief Scientific Officer, Ranga Sarangarajan talks to Liz Harley at Frontline Genomics about our Phase I/II glioblastoma multiforme trials that are being guided by BERG’s AI platform. Learn more here.

Recent news

BERG in the News!

BERG is making headlines.  Click here to see the latest breaking news, interviews, and press releases.